1. Home
  2. GBIO vs GDC Comparison

GBIO vs GDC Comparison

Compare GBIO & GDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • GDC
  • Stock Information
  • Founded
  • GBIO 2016
  • GDC 2015
  • Country
  • GBIO United States
  • GDC United States
  • Employees
  • GBIO N/A
  • GDC N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • GDC Steel/Iron Ore
  • Sector
  • GBIO Health Care
  • GDC Industrials
  • Exchange
  • GBIO Nasdaq
  • GDC Nasdaq
  • Market Cap
  • GBIO 29.2M
  • GDC 29.0M
  • IPO Year
  • GBIO 2020
  • GDC N/A
  • Fundamental
  • Price
  • GBIO $0.39
  • GDC $3.80
  • Analyst Decision
  • GBIO Strong Buy
  • GDC
  • Analyst Count
  • GBIO 4
  • GDC 0
  • Target Price
  • GBIO $7.33
  • GDC N/A
  • AVG Volume (30 Days)
  • GBIO 1.1M
  • GDC 170.3K
  • Earning Date
  • GBIO 08-06-2025
  • GDC 08-13-2025
  • Dividend Yield
  • GBIO N/A
  • GDC N/A
  • EPS Growth
  • GBIO N/A
  • GDC N/A
  • EPS
  • GBIO N/A
  • GDC N/A
  • Revenue
  • GBIO $24,556,000.00
  • GDC N/A
  • Revenue This Year
  • GBIO N/A
  • GDC N/A
  • Revenue Next Year
  • GBIO N/A
  • GDC N/A
  • P/E Ratio
  • GBIO N/A
  • GDC N/A
  • Revenue Growth
  • GBIO 146.47
  • GDC N/A
  • 52 Week Low
  • GBIO $0.30
  • GDC $1.03
  • 52 Week High
  • GBIO $3.65
  • GDC $12.18
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 52.02
  • GDC 68.42
  • Support Level
  • GBIO $0.32
  • GDC $3.47
  • Resistance Level
  • GBIO $0.36
  • GDC $4.00
  • Average True Range (ATR)
  • GBIO 0.03
  • GDC 0.34
  • MACD
  • GBIO 0.00
  • GDC 0.04
  • Stochastic Oscillator
  • GBIO 81.00
  • GDC 88.79

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About GDC GD Culture Group Limited

GD Culture Group Ltd focuses its business on two segments mainly through the Company and two subsidiaries. 1) AI-driven digital human creation and customization; 2) Live streaming and e-commerce. The company has relentlessly been focusing on serving its customers and creating value for them through the continual innovation and optimization of its products and services. For the AI-driven digital human creation and customization sector, the Company uses AI algorithms and software to generate realistic 3D or 2D digital human models. AI algorithms and machine learning models are used to simulate human characteristics, such as facial expressions, body movements, and even speech patterns.

Share on Social Networks: